"
Team:Westminster/Team
From 2012.igem.org
S.berciano (Talk | contribs) |
S.berciano (Talk | contribs) |
||
| Line 164: | Line 164: | ||
<li><a href="https://2012.igem.org/Team:Westminster/Parts"class="navlink">Parts</a></li> | <li><a href="https://2012.igem.org/Team:Westminster/Parts"class="navlink">Parts</a></li> | ||
<li><a href="https://2012.igem.org/Team:Westminster/Modeling"class="navlink">Modeling</a></li> | <li><a href="https://2012.igem.org/Team:Westminster/Modeling"class="navlink">Modeling</a></li> | ||
| - | <li><a href="https://2012.igem.org/Team:Westminster/Notebook"class="navlink"> | + | <li><a href="https://2012.igem.org/Team:Westminster/Notebook"class="navlink">Outreach</a></li> |
<li><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li> | <li><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li> | ||
<li><a href="https://2012.igem.org/Team:Westminster/Attributions"class="navlink">Attributions</a></li> | <li><a href="https://2012.igem.org/Team:Westminster/Attributions"class="navlink">Attributions</a></li> | ||
Revision as of 18:09, 26 September 2012
Lorem Ipsum
Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.
Who we are
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Etiam sit amet elit vitae arcu interdum ullamcorper. Nullam ultrices, nisi quis scelerisque convallis, augue neque tempor enim, et mattis justo nibh eu elit.
Official Team Profile
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Etiam sit amet elit vitae arcu interdum ullamcorper. Nullam ultrices, nisi quis scelerisque convallis, augue neque tempor enim, et mattis justo nibh eu elit.
Attributions
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Etiam sit amet elit vitae arcu interdum ullamcorper. Nullam ultrices, nisi quis scelerisque convallis, augue neque tempor enim, et mattis justo nibh eu elit.
